Novo Medi Sciences Profile
Key Indicators
- Authorised Capital ₹ 19.70 Cr
as on 16-11-2024
- Paid Up Capital ₹ 19.70 Cr
as on 16-11-2024
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 29.75 Cr
as on 16-11-2024
- Satisfied Charges ₹ 52.63 Cr
as on 16-11-2024
- Revenue -2.57%
(FY 2023)
- Profit -3.36%
(FY 2023)
- Ebitda -20.31%
(FY 2023)
- Net Worth 2.34%
(FY 2023)
- Total Assets -15.97%
(FY 2023)
About Novo Medi Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 19.70 Cr and a paid-up capital of Rs 19.70 Cr.
The company currently has active open charges totaling ₹29.75 Cr. The company has closed loans amounting to ₹52.63 Cr, as per Ministry of Corporate Affairs (MCA) records.
Karan Bhagat, Forum Bhagat, Vipulkumar Bhagat, and One other member serve as directors at the Company.
- CIN/LLPIN
U33110MH2013PTC245027
- Company No.
245027
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Novo Medi Sciences Private Limited offer?
Novo Medi Sciences Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Injection, Antibacterial Drugs, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Agent, Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections.
Who are the key members and board of directors at Novo Medi Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Forum Bhagat  | Director | 15-Sep-2015 | Current |
| Anju Kaudanya | Director | 29-Jun-2013 | Current |
| Karan Bhagat | Director | 30-Sep-2016 | Current |
| Vipulkumar Bhagat | Director | 29-Jun-2013 | Current |
Financial Performance of Novo Medi Sciences.
Novo Medi Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.57% decrease. The company also saw a slight decrease in profitability, with a 3.36% decrease in profit. The company's net worth moved up by a moderate rise of 2.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novo Medi Sciences?
In 2023, Novo Medi Sciences had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Novo Biologicals Private LimitedActive 1 year 2 monthsKaran Bhagat, Forum Bhagat and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Nov 2023 | ₹29.75 Cr | Open |
Others Creation Date: 17 Sep 2021 | ₹1.25 Cr | Satisfied |
Others Creation Date: 17 Sep 2021 | ₹1.42 Cr | Satisfied |
How Many Employees Work at Novo Medi Sciences?
Novo Medi Sciences has a workforce of 262 employees as of Apr 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novo Medi Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Medi Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
